Specifications
- 0.5 ml at 10 mg/ml
- UGT and CYP4A characterization
Description
Our human kidney microsomes provide a high-quality in vitro system for studying renal drug metabolism. Isolated from human kidney tissue, these microsomes are enriched in membrane-bound metabolic enzymes, including cytochrome P450s and Phase II conjugation enzymes, relevant to kidney-specific biotransformation. Ideal for assessing extrahepatic metabolism, renal clearance, and drug-drug interactions, these microsomes offer a reliable and reproducible platform for drug discovery and development

